Workflow
康辰药业(603590) - 2020 Q3 - 季度财报
KonrunsKonruns(SH:603590)2020-10-19 16:00

Financial Performance - Operating revenue decreased by 27.75% to CNY 550,025,351.30 for the period from January to September[7] - Net profit attributable to shareholders decreased by 30.41% to CNY 141,758,055.44 for the same period[7] - Basic and diluted earnings per share decreased by 30.12% to CNY 0.8897[8] - Net profit after deducting non-recurring gains and losses decreased by 31.68% to CNY 121,988,161.58[7] - The weighted average return on equity decreased by 3.09 percentage points to 4.94%[7] - Total operating revenue for Q3 2020 was ¥202,021,985.97, a decrease of 7.5% compared to ¥217,664,838.37 in Q3 2019[25] - Net profit for Q3 2020 was ¥38,701,931.91, a decline of 28.8% from ¥54,299,256.04 in Q3 2019[27] - Earnings per share for Q3 2020 was ¥0.2456, compared to ¥0.3394 in Q3 2019[28] - The company reported a total comprehensive income of ¥71,716,427.38 for Q3 2020, down from ¥119,146,202.31 in Q3 2019[28] - The total comprehensive income for Q3 2020 was ¥80.46 million, down 33.7% from ¥121.27 million in Q3 2019[31] Cash Flow - Cash flow from operating activities decreased by 68.64% to CNY 65,450,208.91 compared to the previous year[7] - Operating cash flow for the first nine months of 2020 was 65,450,208.91 CNY, down 68.64% compared to 208,694,402.62 CNY in the same period of 2019, primarily due to decreased sales revenue and collections impacted by the pandemic[15] - The cash flow from operating activities for the first three quarters of 2020 totaled ¥784,827,983.47, down from ¥943,011,307.57 in the same period last year[35] - In Q3 2020, the company reported a net cash flow from operating activities of ¥89,620,336.90, a decrease of 57.6% compared to ¥210,081,197.89 in Q3 2019[36] - The company’s cash flow from financing activities showed a net outflow of ¥564,917,295.37, compared to a net outflow of ¥80,000,000.00 in Q3 2019[36] Assets and Liabilities - Total assets increased by 18.88% to CNY 3,773,001,207.71 compared to the end of the previous year[7] - Current assets decreased to 1,759,263,767.02 CNY from 2,098,369,476.02 CNY, reflecting a decline in cash and receivables[18] - Total liabilities increased to 811,011,835.71 CNY from 445,844,690.19 CNY, indicating a rise in current liabilities[20] - The company's total equity rose to 2,961,989,372.00 CNY from 2,727,998,110.33 CNY, showing growth in shareholder equity[20] - Total liabilities amounted to ¥445,844,690.19, while total equity reached ¥2,727,998,110.33, resulting in total assets of ¥3,173,842,800.52[41] Shareholder Information - The total number of shareholders at the end of the reporting period is not specified in the provided content[11] - Total number of shareholders reached 15,309[12] - Liu Jianhua holds 50,786,760 shares, accounting for 31.74% of total shares[12] Inventory and Receivables - Accounts receivable decreased by 31.92% to 147,110,830.93 due to collection of receivables[13] - Inventory increased by 145.44% to 34,984,454.67 due to higher stock levels[13] Other Financial Metrics - Government subsidies recognized during the period amounted to CNY 24,464,177.11[9] - Other non-recurring gains and losses totaled CNY 5,477,281.77 for the period[10] - Significant decrease in trading financial assets by 100% due to maturity of financial products[13] - Investment income increased by 35.54% to 11,640,477.47 due to higher dividend income[14] - Other comprehensive income increased by 558.02% to 203,030,251.51 due to changes in fair value of equity instruments[14] - Goodwill increased due to the acquisition of the Micai business[14]